White House eyes value-based payment models for drugs and devices

White House eyes value-based payment models for drugs and devices-modernhealthcare: The Trump administration's ideal policymaking agenda would rely heavily on voluntary value-based purchasing for drugs and devices, work requirements to enroll in Medicaid and an end to the ban on using federal dollars to pay for inpatient mental health and substance abuse disorder treatment.